Tbx15 controls skeletal muscle fibre-type determination and muscle metabolism

Nature Communications

Volumn 6, Issue , 2015, Pages

  Lee, Kevin Y ^a   Singh, Manvendra K ^b,c   Ussar, Siegfried ^a,d   Wetzel, Petra ^b   Hirshman, Michael F ^a   Goodyear, Laurie J ^a   Kispert, Andreas ^b   Kahn, C Ronald ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c DEPARTMENT OF CARDIOLOGY   (Singapore)

^d Helmholtz Research Center   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; SOMATOMEDIN B; TBX15 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; FAT INTAKE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IGF2 PROTEIN, MOUSE; T BOX TRANSCRIPTION FACTOR; TBX15 PROTEIN, MOUSE;

BIOCHEMISTRY; BIOENERGETICS; GENE EXPRESSION; GLUCOSE; METABOLISM; MUSCLE; OXYGEN; PHYSIOLOGY; SKELETAL REMAINS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLUCOSE INTOLERANCE; GLYCOLYSIS; MOUSE; MUSCLE CONTRACTION; MUSCLE METABOLISM; MUSCLE RELAXATION; NONHUMAN; OBESITY; OXYGEN CONSUMPTION; PROTEIN EXPRESSION; SKELETAL MUSCLE; ADMINISTRATION AND DOSAGE; ADVERSE EFFECTS; ANIMAL; CELL LINE; CHEMICALLY INDUCED; CLASSIFICATION; FAT INTAKE; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; MALE; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY; SKELETAL MUSCLE CELL;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CELL LINE; DIETARY FATS; GENE EXPRESSION REGULATION; GLUCOSE INTOLERANCE; INSULIN-LIKE GROWTH FACTOR II; MALE; MICE; MICE, KNOCKOUT; MUSCLE CONTRACTION; MUSCLE FIBERS, SKELETAL; OBESITY; OXIDATION-REDUCTION; T-BOX DOMAIN PROTEINS;

EID: 84940056584     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms9054     Document Type: Article

References (47)

1. He, J., Watkins, S. & Kelley, D. E. Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. Diabetes 50, 817 (2001).
2. Hickey, M. S. et al. Skeletal muscle fiber composition is related to adiposity and in vitro glucose transport rate in humans. Am. J. Physiol. 268, E453-E457 (1995).
3. Nyholm, B. et al. Evidence of an increased number of type IIb muscle fibers in insulin-resistant first-degree relatives of patients with NIDDM. Diabetes 46, 1822 (1997).
4. Tanner, C. J. et al. Muscle fiber type is associated with obesity and weight loss. Am. J. Physiol. Endocrinol. Metab. 282, E1191-E1196 (2002).
5. Marin, P., Andersson, B., Krotkiewski, M. & Bjorntorp, P. Muscle fiber composition and capillary density in women and men with NIDDM. Diabetes Care 17, 382 (1994).
6. Chin, E. R. et al. A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev. 12, 2499 (1998).
7. DiMario, J. X. Protein kinase C signaling controls skeletal muscle fiber types. Exp. Cell Res. 263, 23 (2001).
8. Fryer, L. G. et al. Characterization of the role of the AMP-Activated protein kinase in the stimulation of glucose transport in skeletal muscle cells. Biochem. J. 363, 167 (2002).
9. Lin, J. et al. Transcriptional co-Activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 418, 797 (2002).
10. Rockl, K. S. et al. Skeletal muscle adaptation to exercise training: AMP-Activated protein kinase mediates muscle fiber type shift. Diabetes 56, 2062 (2007).
11. Meng, Z. X. et al. Baf60c drives glycolytic metabolism in the muscle and improves systemic glucose homeostasis through Deptor-mediated Akt activation. Nat. Med. 19, 640 (2013).
12. Herrmann, B. G., Labeit, S., Poustka, A., King, T. R. & Lehrach, H. Cloning of the T gene required in mesoderm formation in the mouse. Nature 343, 617 (1990).
13. Kispert, A. & Herrmann, B. G. The Brachyury gene encodes a novel DNA binding protein. EMBO J. 12, 3211 (1993).
14. Takashima, Y. & Suzuki, A. Regulation of organogenesis and stem cell properties by T-box transcription factors. Cell. Mol. Life Sci. 70, 3929 (2013).
15. Candille, S. I. et al. Dorsoventral patterning of the mouse coat by Tbx15. PLoS Biol. 2, E3 (2004).
16. Lausch, E. et al. TBX15 mutations cause craniofacial dysmorphism, hypoplasia of scapula and pelvis, and short stature in Cousin syndrome. Am. J. Hum. Genet. 83, 649 (2008).
17. Singh, M. K. et al. The T-box transcription factor Tbx15 is required for skeletal development. Mech. Dev. 122, 131 (2005).
18. Farin, H. F. et al. Transcriptional repression by the T-box proteins Tbx18 and Tbx15 depends on Groucho corepressors. J. Biol. Chem. 282, 25748 (2007).
19. Gesta, S. et al. Evidence for a role of developmental genes in the origin of obesity and body fat distribution. Proc. Natl Acad. Sci. USA 103, 6676 (2006).
20. Heid, I. M. et al. Meta-Analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat. Genet. 42, 949 (2010).
21. Gesta, S. et al. Mesodermal developmental gene Tbx15 impairs adipocyte differentiation and mitochondrial respiration. Proc. Natl Acad. Sci. USA 108, 2771 (2011).
22. Lin, J., Handschin, C. & Spiegelman, B. M. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab. 1, 361 (2005).
23. LeBrasseur, N. K., Walsh, K. & Arany, Z. Metabolic benefits of resistance training and fast glycolytic skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 300, E3 (2011).
24. Witczak, C. A., Sharoff, C. G. & Goodyear, L. J. AMP-Activated protein kinase in skeletal muscle: from structure and localization to its role as a master regulator of cellular metabolism. Cell. Mol. Life Sci. 65, 3737 (2008).
25. Ruderman, N. B., Carling, D., Prentki, M. & Cacicedo, J. M. AMPK, insulin resistance, and the metabolic syndrome. J. Clin. Invest. 123, 2764 (2013).
26. Sarbassov, D. D., Ali, S. M. & Sabatini, D. M. Growing roles for the mTOR pathway. Curr. Opin. Cell Biol. 17, 596 (2005).
27. Florini, J. R. et al. Spontaneous differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II. J. Biol. Chem. 266, 15917 (1991).
28. Merrick, D., Ting, T., Stadler, L. K. & Smith, J. A role for Insulin-like growth factor 2 in specification of the fast skeletal muscle fibre. BMC Dev. Biol. 7, 65 (2007).
29. DeChiara, T. M., Efstratiadis, A. & Robertson, E. J. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345, 78 (1990).
30. Alzhanov, D. T., McInerney, S. F. & Rotwein, P. Long range interactions regulate Igf2 gene transcription during skeletal muscle differentiation. J. Biol. Chem. 285, 38969 (2010).
31. Akpan, I. et al. The effects of a soluble activin type IIB receptor on obesity and insulin sensitivity. Int. J. Obes. (Lond) 33, 1265 (2009).
32. Guo, T. et al. Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity. PLoS ONE 4, e4937 (2009).
33. Izumiya, Y. et al. Fast/glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice. Cell Metab. 7, 159 (2008).
34. Gburcik, V., Cawthorn, W. P., Nedergaard, J., Timmons, J. A. & Cannon, B. An essential role for Tbx15 in the differentiation of brown and "brite" but not white adipocytes. Am. J. Physiol. Endocrinol. Metab. 303, E1053-E1060 (2012).
35. Lee-Young, R. S. et al. Skeletal muscle AMP-Activated protein kinase is essential for the metabolic response to exercise in vivo. J. Biol. Chem. 284, 23925 (2009).
36. Rockl, K. S., Witczak, C. A. & Goodyear, L. J. Signaling mechanisms in skeletal muscle: acute responses and chronic adaptations to exercise. IUBMB Life 60, 145 (2008).
37. Bimber, B., Dettman, R. W. & Simon, H. G. Differential regulation of Tbx5 protein expression and sub-cellular localization during heart development. Dev. Biol. 302, 230 (2007).
38. Krcmery, J., Camarata, T., Kulisz, A. & Simon, H. G. Nucleocytoplasmic functions of the PDZ-LIM protein family: new insights into organ development. Bioessays 32, 100 (2010).
39. Pallafacchina, G., Calabria, E., Serrano, A. L., Kalhovde, J. M. & Schiaffino, S. A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification. Proc. Natl Acad. Sci. USA 99, 9213 (2002).
40. Frezza, C., Cipolat, S. & Scorrano, L. Measuring mitochondrial shape changes and their consequences on mitochondrial involvement during apoptosis. Methods Mol. Biol. 372, 405 (2007).
41. McKeel, D. W. & Jarett, L. Preparation and characterization of a plasma membrane fraction from isolated fat cells. J. Cell Biol. 44, 417 (1970).
42. Wetzel, P., Kleinke, T., Papadopoulos, S. & Gros, G. Inhibition of muscle carbonic anhydrase slows the Ca(2) transient in rat skeletal muscle fibers. Am. J. Physiol. Cell Physiol. 283, C1242-C1253 (2002).
43. Cerletti, M. et al. Highly efficient, functional engraftment of skeletal muscle stem cells in dystrophic muscles. Cell 134, 37 (2008).
44. Hayashi, T., Hirshman, M. F., Kurth, E. J., Winder, W. W. & Goodyear, L. J. Evidence for 5' AMP-Activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 47, 1369 (1998).
45. Rowe, G. C. et al. Disconnecting mitochondrial content from respiratory chain capacity in PGC-1-deficient skeletal muscle. Cell Rep. 3, 1449 (2013).
46. Sinha, M. et al. Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle. Science 344, 649 (2014).
47. Fujii, N. et al. Role of AMP-Activated protein kinase in exercise capacity, whole body glucose homeostasis, and glucose transport in skeletal muscle-insight from analysis of a transgenic mouse model. Diabetes Res. Clin. Pract. 77(Suppl 1): S92-S98 (2007).